427 filings
Page 8 of 22
6-K
eerssi1awb
21 Oct 16
Current report (foreign)
12:00am
6-K
4imbjba
11 Oct 16
Sinovac Schedules 2016 Annual Meeting of Shareholders
12:00am
6-K
baq3z
24 Aug 16
Sinovac Reports Unaudited Second Quarter 2016 Financial Results
12:00am
6-K
ktdev3 v6z
2 Jun 16
Sinovac Reports Unaudited First Quarter 2016 Financial Results
12:00am
6-K
wba000arzt35h
14 Apr 16
Sinovac Special Committee Engages Financial and Legal Advisors
12:00am
6-K
m9mrh gs84
12 Apr 16
Current report (foreign)
12:00am
6-K
6es7 4xt1xfzj56
29 Mar 16
Sinovac Adopts Shareholder Rights Plan and Declares Dividend Distribution of Preferred Share Purchase Rights
12:00am
8-A12B
1xvx0n56yus0ml9wej5i
29 Mar 16
Registration of securities on exchange
12:00am
6-K
1pdi2houpbv514biwh
4 Feb 16
Sinovac Announces Receipt of Competing Non-Binding “Going Private” Proposal
12:00am
6-K
rxlza568whl0 l3o
1 Feb 16
Sinovac Biotech Announces Issuance of GMP Certificate for EV71 Vaccine
12:00am
6-K
uvv4ei
1 Feb 16
Sinovac Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the Company and Formation of Independent Special Committee
12:00am
6-K
n50san09w 37qe3og3
5 Jan 16
Sinovac Obtains Clinical Trial Approval for Sabin-IPV Candidate
12:00am
6-K
vxhs moqhx
13 Nov 15
Sinovac Reports Unaudited Third Quarter Financial Results
12:00am
6-K
wejkg3pfw52wi
6 Nov 15
Sinovac to Host Conference Call to Report Third Quarter 2015 Unaudited Financial Results
12:00am
6-K
bwq77nnxp xvilh
2 Nov 15
Sinovac Receives Clinical Trial Approval for Varicella Vaccine Candidate
12:00am
6-K
y3tri6r 52r
15 Sep 15
Sinovac to Participate in Morgan Stanley Global Healthcare Conference
12:00am
6-K
5b37jgpt
13 Aug 15
Sinovac to Host Conference Call to Report Second Quarter 2015 Unaudited Financial Results
12:00am
6-K
cot0dglt95hb hs6wyw0
15 May 15
Sinovac Reports Unaudited First Quarter 2015 Financial Results
12:00am
6-K
dg9zhja
14 May 15
Sinovac Receives Site Inspection Notification for EV71 Vaccine Production Facilities
12:00am